ea0037ep885 | Thyroid cancer | ECE2015
Glynn Nigel
, Hannon Anne Marie
, Schneekloth Lauren
, De Buitleir Ciara
, Morrin Martina
, Keeling Frank
, Faul Clare
, Leader Mary
, Hill Arnold D K
, Tormey William
, Smith Diarmuid
, Thompson Chris J
, Agha Amar
Introduction: TSH-stimulated serum thyroglobulin (Tg) is used as a sensitive marker for the detection of early recurrence or residual disease following treatment for differentiated thyroid cancer (DTC). However, stimulated Tg, using TSH or thyroid hormone withdrawal, is either costly or cumbersome for patients.Aim: To compare the performance of basal T4 suppressed, with stimulated Tg measurement, in the follow up of patients treated for DTC.</...